NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
TOKYO, May 6, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) and NEC Solution Innovators today announced the successful development of artificial DNA aptamers (1) that bind to the novel coronavirus (SARS-CoV-2). This breakthrough stems from the NEC Group’s efforts to promote spatial monitoring business using aptamers, including the development of new... » read more